AMPH (STOCKS)
Amphastar Pharmaceuticals, Inc.
$21.360000
+0.990000 (+4.86%)
Prev close: $20.370000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Yong Feng Zhang
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $969.11M
- Employees
- 2,028
- P/E (TTM)
- 10.01
- P/B (TTM)
- 1.18
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $719.89M |
| Benefits Costs and Expenses | $596.26M |
| Cost Of Revenue | $363.83M |
| Costs And Expenses | $596.26M |
| Gross Profit | $356.06M |
| Nonoperating Income/Loss | -$16.78M |
| Operating Expenses | $215.65M |
| Research and Development | $85.84M |
| Other Operating Expenses | $129.81M |
| Operating Income/Loss | $140.40M |
| Income/Loss From Continuing Operations After Tax | $98.09M |
| Income/Loss From Continuing Operations Before Tax | $123.62M |
| Income Tax Expense/Benefit | $25.53M |
| Income Tax Expense/Benefit, Current | -$3.13M |
| Income Tax Expense/Benefit, Deferred | $28.66M |
| Net Income/Loss | $98.09M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $98.09M |
| Net Income/Loss Available To Common Stockholders, Basic | $98.09M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $2.10 |
| Diluted Earnings Per Share | $2.03 |
| Basic Average Shares | 46,743,000 |
| Diluted Average Shares | 48,215,000 |
| Assets | $1.63B |
| Current Assets | $636.02M |
| Inventory | $176.89M |
| Other Current Assets | $459.13M |
| Noncurrent Assets | $993.28M |
| Fixed Assets | $310.57M |
| Other Non-current Assets | $682.72M |
| Liabilities | $840.49M |
| Current Liabilities | $158.16M |
| Accounts Payable | $32.59M |
| Wages | $26.32M |
| Other Current Liabilities | $99.25M |
| Noncurrent Liabilities | $682.34M |
| Equity | $788.81M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $788.81M |
| Liabilities And Equity | $1.63B |
| Net Cash Flow From Operating Activities | $156.12M |
| Net Cash Flow From Operating Activities, Continuing | $156.12M |
| Net Cash Flow From Investing Activities | -$70.33M |
| Net Cash Flow From Investing Activities, Continuing | -$70.33M |
| Net Cash Flow From Financing Activities | -$67.43M |
| Net Cash Flow From Financing Activities, Continuing | -$67.43M |
| Exchange Gains/Losses | $210.00K |
| Net Cash Flow | $18.57M |
| Net Cash Flow, Continuing | $18.36M |
| Comprehensive Income/Loss | $101.96M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $101.96M |
| Other Comprehensive Income/Loss | $3.87M |
| Other Comprehensive Income/Loss Attributable To Parent | $3.87M |